Sanofi (Sanofi) Days Payable

: 372.99 (As of Jun. 2023)

View and export this data going back to 2002. Start your Free Trial

Sanofi's average Accounts Payable for the six months ended in Jun. 2023 was $14,054 Mil. Sanofi's Cost of Goods Sold for the six months ended in Jun. 2023 was $6,876 Mil. Hence, Sanofi's Days Payable for the six months ended in Jun. 2023 was 372.99.

The historical rank and industry rank for Sanofi's Days Payable or its related term are showing as below:

SNY' s Days Payable Range Over the Past 10 Years
Min: 118.71 Med: 156.07 Max: 285.65
Current: 285.65

During the past 13 years, Sanofi's highest Days Payable was 285.65. The lowest was 118.71. And the median was 156.07.

SNY's Days Payable is ranked better than
88.87% of 979 companies
in the Drug Manufacturers industry
Industry Median: 87.01 vs SNY: 285.65

Sanofi's Days Payable increased from Jun. 2022 (195.96) to Jun. 2023 (372.99). It may suggest that Sanofi delayed paying its suppliers.

Sanofi Days Payable Historical Data

The historical data trend for Sanofi's Days Payable can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Sanofi Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Days Payable

159.58

165.59

191.12

178.64

178.78

Sanofi Semi-Annual Data
	Jun14	Dec14	Jun15	Dec15	Jun16	Dec16	Jun17	Dec17	Jun18	Dec18	Jun19	Dec19	Jun20	Dec20	Jun21	Dec21	Jun22	Dec22	Jun23	Dec23
Days Payable																161.89	195.96	161.12	372.99	306.34

Competitive Comparison

For the Drug Manufacturers - General subindustry, Sanofi's Days Payable, along with its competitors' market caps and Days Payable data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Sanofi Days Payable Distribution

For the Drug Manufacturers industry and Healthcare sector, Sanofi's Days Payable distribution charts can be found below:

* The bar in red indicates where Sanofi's Days Payable falls into.

Sanofi Days Payable Calculation

Days Payable indicates the number of days that the account payable relative to cost of goods sold the company has. An increase of Days Payable may suggest that the company delays paying its suppliers.

Sanofi's Days Payable for the fiscal year that ended in Dec. 2023 is calculated as

	Days Payable (A: Dec. 2023 )
=	Average Accounts Payable					/	Cost of Goods Sold	*	Days in Period
=	( (Accounts Payable (A: Dec. 2022 )	+	Accounts Payable (A: Dec. 2023 ))	/	count )	/	Cost of Goods Sold (A: Dec. 2023 )	*	Days in Period
=	( (7217.161	+	7991.276)	/	2 )	/	15524.536	*	365
=	7604.2185					/	15524.536	*	365
=	178.78

Sanofi's Days Payable for the quarter that ended in Jun. 2023 is calculated as:

	Days Payable (Q: Jun. 2023 )
=	Average Accounts Payable					/	Cost of Goods Sold	*	Days in Period
=	( (Accounts Payable (Q: Dec. 2022 )	+	Accounts Payable (Q: Jun. 2023 ))	/	count )	/	Cost of Goods Sold (Q: Jun. 2023 )	*	Days in Period
=	( (7217.161	+	20890.574)	/	2 )	/	6876.49	*	365 / 2
=	14053.8675					/	6876.49	*	365 / 2
=	372.99

Sanofi Days Payable Related Terms

Thank you for viewing the detailed overview of Sanofi's Days Payable provided by GuruFocus.com. Please click on the following links to see related term pages.

Sanofi (Sanofi) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Sanofi SA (NAS:SNY) » Definitions » Days Payable

Comparable Companies

Traded in Other Exchanges

SNYNF:USA SNY:Mexico SANF:Italy 0A2V:UK SANp:UK 0O59:UK SAN:France SNW:Germany SNW2:Germany SNW:Germany SNW:Germany SNW2:Germany SNW:Germany SANO:Austria

Address

46, avenue de la Grande Armée, Paris, FRA, 75017

Website

https://www.sanofi.com

Sanofi develops and markets drugs with a concentration in oncology, immunology, cardiovascular disease, diabetes, and vaccines. However, the company's decision in late 2019 to pull back from the cardio-metabolic area will likely reduce the firm's footprint in this large therapeutic area. The company offers a diverse array of drugs with its highest revenue generator, Dupixent, representing just over 15% of total sales, but profits are shared with Regeneron. About 40% of total revenue comes from the United States and 25% from Europe. Emerging markets represent the majority of the remainder of revenue.